5. Stover J, Ross J. How increased contraceptive use has reduced maternal mortality.
Matern Child Health J. 2010;14(5):687–95.
6. Pickle S, Wu J, Burbank-Schmitt E. Prevention of unintended pregnancy: a focus on
long-acting reversible contraception. Prim Care - Clin Off Pract. 2014;41(2):239–60.
Available from: http://dx.doi.org/10.1016/j.pop.2014.02.004
8. BKKBN. Strategi Pelaksanaan Program Keluarga Berencana Berbasis Hak untuk Percepatan Akses
terhadap Pelayanan Keluarga Berencana dan Kesehatan Reproduksi yang Terintegrasi dalam
Mencapai Tujuan Pembangunan Indonesia. 2015;100. A report by BKKBN.
9. Rahayu R, Utomo I, Mcdonald P. Contraceptive use pattern among married women in Indonesia.
Int Conf Fam Plan Res Best Pract. 2009;36.
10. Juan B, Schoemaker J. 3110605-5. 2003;106–14.
14.
Rusady MA.
Peranan BPJS Kesehatan Dalam Peningkatan Pelayanan Kesehatan [The role of BPJS to increase health services]. Report by BPJS.2017.
18.
Trisnantoro L.
Kebijakan Pembiayaan dan Fragmentasi Sistem Kesehatan [Financing Policy and Health System Fragmentation]. Gadjah Mada University Press;
2019.
19.
Pemerintah RI.
Undang-Undang No.23 Tahun 2014 tentang Pemerintah Daerah [The Law of Indonesia Republic No.23/2014; Local Government].
20.
Pemerintah RI. Peraturan Presiden Republik Indonesia No. 19 Tahun 2016 tentang Perubahan Kedua atas
Peraturan Presiden No. 12 tahun 2013 tentang Jaminan Kesehatan. Pemerintah RI.
[The Law of Indonesia Republic No.19/2016]
21.
Pemerintah RI.
Undang-Undang No.36 Tahun 2009 tentang Kesehatan [The Law of Indonesia Republic No.36/2009; Health].
22. Siswosudarmo R. The Utilisation of Post-partum Family Planning. Presented in National
Forum of Maternal and Child Health, Universitas Gadjah Mada, Indonesia, 2018.
23.
Pemerintah RI.
Permenkes 2562/Menkes/PER/XII/2011 [The Law of Health Ministry No.2562/2011].
24. Philibert A, Ravit M, Ridde V, Dossa I, Bonnet E, Bedecarrats F, et al. Maternal and
neonatal health impact of obstetrical risk insurance scheme in Mauritania: A quasi
experimental before-and-after study. Health Policy Plan. 2017;32(3):405–17.
27. Thompson KMJ, Rocca CH, Kohn JE, Goodman S, Stern L, Blum M, et al. Public funding
for contraception, provider training, and use of highly effective contraceptives:
A cluster randomized trial. Am J Public Health. 2016;106(3):541–6.
28. Durante JC, Woodhams EJ. Patient education about the Affordable Care Act contraceptive
coverage requirement increases interest in using long-acting reversible contraception.
Women’s Health Issues [Internet]. 2017;27(2):152–7. Available from: http://dx.doi.org/10.1016/j.whi.2016.11.006
32. Dunlop AL, Adams EK, Hawley J, Blake SC, Joski P. Georgia’s Medicaid family planning
waiver: working together with Title X to enhance access to and use of contraceptive
and preventive health services. Women’s Health Issues. 2016;26(6):602–11. Available
from: http://dx.doi.org/10.1016/j.whi.2016.07.006
33. Adams EK, Galactionova K, Kenney GM. Medicaid family planning waivers in 3 states:
did they reduce unwanted births? Inq (United States). 2015;52.
34. Bearak JM, Finer LB, Jerman J, Kavanaugh ML. Changes in out-of-pocket costs for hormonal
IUDs after implementation of the Affordable Care Act: An analysis of insurance benefit
inquiries. Contraception. 2016;93(2):139–44. Available from: http://dx.doi.org/10.1016/j.contraception.2015.08.018
35. Parks C, Peipert JF. Eliminating health disparities in unintended pregnancy with long-acting
reversible contraception (LARC) Presented in part at the 2013 annual meeting of the
American Gynecological and Obstetrical Society. Am J Obstet Gynecol. 2016;214(6):681–8.
Available from: http://dx.doi.org/10.1016/j.ajog.2016.02.017
36. Hossain M, Khan M, Ababneh F, Shaw J. Identifying factors influencing contraceptive
use in Bangladesh: evidence from BDHS 2014 data. BMC Public Health. 2018;18(1):1–14.
38. Njotang PN, Yakum MN, Ajong AB, Essi MJ, Akoh EW, Mesumbe NE, et al. Determinants
of modern contraceptive practice in Yaoundé-Cameroon: A community based cross sectional
study. BMC Res Notes. 2017;10(1):4–9.
39. Medhanyie AA, Desta A, Alemayehu M, Gebrehiwot T, Abraha TA, Abrha A, et al. Factors
associated with contraceptive use in Tigray, North Ethiopia. Reprod Health. 2017;14(1):1–11.
41. Holton S, Rowe H, Kirkman M, Jordan L, McNamee K, Bayly C, et al. Long-acting reversible
contraception: findings from the Understanding Fertility Management in Contemporary
Australia Survey. Eur J Contracept Reprod Heal Care. 2016;21(2):116–31. Available
from: http://dx.doi.org/10.3109/13625187.2015.1052394
43. Kim NH, Look KA. Effects of the Affordable Care Act’s contraceptive coverage requirement
on the utilization and out-of-pocket costs of prescribed oral contraceptives. Res
Soc Adm Pharm. 2018;14(5):479–87. Available from: https://doi.org/10.1016/j.sapharm.2017.06.005
45. Law A, Pilon D, Lynen R, Laliberté F, Gozalo L, Lefebvre P, et al. Retrospective analysis
of the impact of increasing access to long acting reversible contraceptives in a commercially
insured population. Reprod Health. 2016;13(1). Available from: http://dx.doi.org/10.1186/s12978-016-0211-3
47. Potter JE, Coleman-minahan K, White K, Powers DA, Dillaway C, Stevenson AJ. Texas:
use compared with preference. Obstet Gynecol. 2018;130(2):393–402.
48. Wilopo SA, Setyawan A, Pinandari AW, Prihyugiarto T, Juliaan F, Magnani RJ. Levels,
trends and correlates of unmet need for family planning among postpartum women in
Indonesia: 2007-2015. BMC Womens Health. 2017;17(1):1–14.